HP
AMGN icon

HealthInvest Partners’s Amgen AMGN Stock Holding History

HealthInvest Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,903
Closed -$8.72M – 40
2026
Q1 		$8.72M Hold
21,903
– – 2.81% 16
2025
Q4 		$7.17M Buy
21,903
+8,097
+59% +$2.57M 2.29% 17
2025
Q3 		$414K Sell
13,806
-10,088
-42% -$2.93M 1.53% 25
2025
Q2 		$6.67M Sell
23,894
-2,683
-10% -$760K 2.86% 13
2025
Q1 		$8.28M Sell
26,577
-837
-3% -$247K 3.66% 12
2024
Q4 		$7.11M Sell
27,414
-1,551
-5% -$460K 3.37% 12
2024
Q3 		$9.33M Buy
28,965
+1,376
+5% +$450K 4.39% 5
2024
Q2 		$8.62M Buy
27,589
+8,698
+46% +$2.56M 5.26% 5
2024
Q1 		$5.37M Buy
18,891
+2,868
+18% +$839K 3.27% 8
2023
Q4 		$4.61M Buy
+16,023
New +$4.37M 3.61% 9

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HealthInvest Partners's AMGN Position: Q2 2026 in Review

HealthInvest Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 21,903 shares — an estimated $8.72M sold.

HealthInvest Partners first reported a position in AMGN in Q4 2023 and held it in 10 quarters. The position peaked at $9.33M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HealthInvest Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • HealthInvest Partners sold 21,903 Amgen shares in Q2 2026, an estimated $8.72M.
  • HealthInvest Partners first reported a position in Amgen in Q4 2023 and held it in 10 quarters.
  • HealthInvest Partners's Amgen position peaked at $9.33M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.